Cite
HARVARD Citation
Zhao, L. et al. (2019). Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin®-activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancer. Immunotherapy. pp. 273-282. [Online].